TrialJAMA oncology2018

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.

Stephen J Luen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.